Quantitative morphometric analysis of fine needle aspirates of breast carcinoma

Breast Cancer

Volumn 8, Issue 2, 2001, Pages 138-145

  Suzuki, Masato ^a   Oshida, Masaki ^a   Nagashima, Takeshi ^a   Hashimoto, Hideyuki ^a   Yagata, Hiroshi ^a   Nakajima, Nobuyuki ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast carcinoma; Chemosensitivity; Fine needle aspiration; Morphometry; Quantitative analysis

Indexed keywords

ARTICLE; BREAST TUMOR; CELL NUCLEUS; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PLOIDY; PROGNOSIS; TUMOR RECURRENCE;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PROGNOSIS;

EID: 0035230259     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967493     Document Type: Article

References (43)

1. Dabbs DJ: Role of nuclear grading of breast carcinomas in fine needle aspiration specimens. Acta Cytol 37:361-366, 1993. (Pubitemid 23154071)
2. Dabbs DJ, Silverman JF: Prognostic factors from the fine-needle aspirate: breast carcinoma nuclear grade. Diagn Cytopathol 10:203-208, 1994. (Pubitemid 24139817)
3. Layfield LJ, Robert ME, Cramer H, et al: Aspiration biopsy smear pattern as a predictor of biologic behavior in adenocarcinoma of the breast. Acta Cytol 36:208-214, 1992.
4. Briffod M, Le Doussal V, Spyratos F: Cytologic nuclear grading of fine needle cytopunctures of breast carcinoma. Comparison with histologic nuclear grading and image cytometric data. Anal Quant Cytol Histol 19:114-122, 1997. (Pubitemid 27176388)
5. Cajulis RS, Hessel RG, Hwang S, et al: Simplified nuclear grading of fine-needle aspirates of breast carcinoma: concordance with corresponding histologic nuclear grading and flow cytometric data. Diagn Cytopathol 11:124-130, 1994. (Pubitemid 24308190)
6. Cajulis RS, Hessel RG, Frias-Hidvegi D, et al: Cytologic grading of fine needle aspirates of breast carcinoma by private practice pathologists. Acta Cytol 41:313-320, 1997. (Pubitemid 27172493)
7. Hunt CM, Ellis IO, Elston CW, et al: Cytological grading of breast carcinoma-a feasible proposition?. Cytopathology 1:287-295, 1990.
8. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377, 1957.
9. Black MM, Barclay TH, Hankey BF: Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer 36:2048-2055, 1975.
10. Fisher B, Fisher ER, Redmond C, et al: Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer. Breast Cancer Res Treat 7:147-160, 1986. (Pubitemid 16004881)
11. Le Doussal V, Tubiana-Hulin M, Friedman S, et al: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64:1914-1921, 1989. (Pubitemid 19267813)
12. Stierer M, Rosen H, Weber R: Nuclear pleomorphism, a strong prognostic factor in axillary nodenegative small invasive breast cancer. Breast Cancer Res Treat 20:109-116, 1992.
13. Davey DD, Banks ER, Jennings D, et al: Comparison of nuclear grade and DNA cytometry in breast carcinoma aspirates to histologic grade in excised cancers. Am J Clin Pathol 99:708-713, 1993. (Pubitemid 23181820)
14. Ducatman BS, Emery ST, Wang HH: Correlation of histologic grade of breast carcinoma with cytologic features on fine-needle aspiration of the breast. Mod Pathol 6:539-543, 1993.
15. Robinson IA, McKee G, Nicholson A, et al: Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet 343:947-949, 1994. (Pubitemid 24117230)
16. Zoppi JA, Pellicer EM, Sundblad AS: Cytohistologic correlation of nuclear grade in breast carcinoma. Acta Cytol 41:701-704, 1997. (Pubitemid 27231221)
17. Moroz K, Lipscomb J, Vial LJ Jr, et al: Cytologic nuclear grade of malignant breast aspirates as a predictor of histologic grade. Light microscopy and image analysis characteristics. Acta Cytol 41:1107-1111, 1997. (Pubitemid 27329688)
18. Pinder SE, Murray S, Ellis IO, et al: The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 83:1529-1539, 1998. (Pubitemid 28465470)
19. Fisher ER, Anderson S, Redmond C, et al: Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 71:2507-2514, 1993. (Pubitemid 23100484)
20. Mouriquand J, Gozlan-Fior M, Villemain D, et al: Value of cytoprognostic classification in breast carcinomas. J Clin Pathol 39:489-496, 1986. (Pubitemid 16071252)
21. Thomas JS, Mallon EA, George WD: Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions. J Clin Pathol 42:28-34, 1989. (Pubitemid 19036903)
22. Stenkvist B, Westman-Naeser S, Holmquist J, et al: Computerized nuclear morphometry as an objective method for characterizing human cancer cell populations. Cancer Res 38:4688-4697, 1978. (Pubitemid 9065153)
23. Wolberg WH, Street WN, Heisey DM, et al: Computerized breast cancer diagnosis and prognosis from fine-needle aspirates. Archives of Surgery 130:511-516, 1995.
24. Kimijima I, Watanabe T, Abe R: Prognostic value of nuclear grading by image cytometry for node negative breast cancer patients. Anticancer Res 16:3949-3954, 1996. (Pubitemid 127663743)
25. Cook AF, Holman MJ, Kramer MJ, et al: Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides. J Med Chem 22:1330-1335, 1979. (Pubitemid 10193598)
26. Miwa M, Ura M, Nishida M, et al: Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34:1274-1281, 1998. (Pubitemid 28342121)
27. Ishikawa T, Sekiguchi F, Fukase Y, et al: Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58:685-690, 1998. (Pubitemid 28099478)
28. Committee for Production of Histopathological Criteria, Japanese Breast Cancer Society: Histopathological criteria for assessment of therapeutic response in breast cancer. Breast Cancer 8:1-2, 2001.
29. Martin HE, Ellis EB: Biopsy of needle puncture and aspiration. Ann Surg 92:169-181, 1930.
30. NIH Consensus Development Conference statement on the treatment of early-stage breast cancer. Oncology 5:120-124, 1991.
31. Stenkvist B, Westman-Naeser S, Vegelius J, et al: Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol 32:979-985, 1979. (Pubitemid 10250550)
32. Baak JP, Persijn JP: In search for the best qualitative microscopical or morphometrical predictor of oestrogen receptor in breast cancer. Pathology, Research & Practice 178:307-314, 1984. (Pubitemid 14145988)
33. Baak JP, Van Dop H, Kurver PH, et al: The value of morphometry to classic prognosticators in breast cancer. Carcer 56:374-382, 1985. (Pubitemid 15031663)
34. Dalton LW, Page DL, Dupont WD: Histologic grading of breast carcinoma. A reproducibility study. Cancer 73:2765-2770, 1994. (Pubitemid 24166264)
35. Robbins P, Pinder S, de Klerk N, et al: Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 26:873-879, 1995.
36. Balslev I, Axelsson CK, Zedeler K, et al: The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 32:281-290, 1994. (Pubitemid 24351375)
37. Galea MH, Blarney RW, Elston CE, et al: The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207-219, 1992.
38. Miyauchi M: Objective evaluation of nuclear grade in preoperative aspiration materials from breast cancers-special reference to the relationship of coefficiency variant of nuclear area with pathological prognostic features. Nippon Geka Gakkai Zasshi 92:1642-1649, 1991.
39. Briffod M, Spyratos F, Tubiana-Hulin M, et al: Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression. Carcer 63:631-637, 1989. (Pubitemid 19050261)
40. Levack PA, Mullen P, Anderson TJ, et al: DNA analysis of breast tumor fine needle aspirates using flow cytometry. Br J Cancer 56:643-646, 1987. (Pubitemid 17165664)
41. Briffod M, Spyratos F, Hacene K, et al: Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis. Cytometry 13:250-258, 1992.
42. Sarker S, Spigelman A, Walker M, et al: Nuclear DNA content of fine needle aspirates of invasive ductal carcinomas of the breast. Anal Cell Pathol 13:1-8, 1997. (Pubitemid 27174569)
43. Ballo MS, Sneige N: Can core needle biopsy replace fine-needle aspiration cytology in the diagnosis of palpable breast carcinoma. Cancer 78:773-737, 1996.